TEL AVIV and REHOVOT, Israel, July 17, 2024 /PRNewswire/ -- ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, and Lavie Bio Ltd., a leading ag-biologicals company and ...

This expansion is in addition to the previously announced Microsoft (MSFT) for Startups program. PredicTcell, Tevogen Bio’s proprietary technology, is designed for predictive, precision T cell target ...

AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional backing from executives at Meta, OpenAI, and Wiz.

"CGIE (TM) is being built as future-facing infrastructure rather than a point solution," said Yusuf Henriques, Founder and CEO of IndyGeneUS Bio. "Our objective is to establish the AI×Bio Factory--the ...

As we approach the end of 2024, First Opinion is publishing a series of essays on the state of AI in medicine and biopharma. There’s more to life than protein folding. You’d be forgiven for believing ...

The plastic needles on your next artificial Christmas tree may actually be plant-based — although not as plant-based as a real tree, of course. Balsam Brands, the company that makes the Balsam Fir ...

Jan 6 (Reuters) - Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic data to discover new drug candidates to send into human ...

GENEVA, Jan. 8, 2026 /PRNewswire/ -- All Here announces the launch of the Bio-Intelligence Initiative, the world's first research program exploring how deep meditative states of stability and silence ...

Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. In today’s column, I analyze the recently announced ...

Superhydrophobicity, superomniphobicity, underwater superoleophobicity, and slippery property are the basis for deriving various functional materials and interfaces for energy, healthcare, and ...

IndyGeneUS Bio today announced the filing of a patent application covering its Clinico-Genomic Insight Engine™ (CGIE™)—a foundational platform under development to support regulated whole-genome ...